Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11193123 Methods and compositions for directed genome editing
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
March 19, 2021
Date of Patent
December 7, 2021
Patent Application Number
17206522
Patent Citations Received
US Patent 12133884 Methods of substituting pathogenic amino acids using programmable base editor systems
0
US Patent 11352623 Methods and compositions for directed genome editing
US Patent 11952571 Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)
0
US Patent 12024728 Methods and compositions for modulating a genome
0
US Patent 12123034 Methods and compositions for modulating a genome
0
US Patent 11572556 Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)
US Patent 11649442 RNA-guided endonuclease fusion polypeptides and methods of use thereof
0
US Patent 11649443 RNA-guided endonuclease fusion polypeptides and methods of use thereof
0
Patent Inventor Names
Schaked Omer Halperin
0
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11193123
Patent Primary Examiner
Antonio Galisteo Gonzalez
Find more entities like US Patent 11193123 Methods and compositions for directed genome editing
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE